Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
184,457
clinical trials

Breast Cancer Clinical Trial
A Study of Debio 1347 Plus Fulvestrant in Patients With Metastatic Breast Cancer
Status: Enrolling, Phase I, II
Updated: 1/19/2018
Memorioal Sloan Kettering Cancer Center
mi
from
New York, NY
Click here to add this to my saved trials
Psychiatry / Psychology Clinical Trial
SafERteens M-Coach
Status: Enrolling
Updated: 5/1/2018
University of Michigan
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Opioid Dependence Clinical Trial
Facilitating Rapid Naltrexone Initiation
Status: Enrolling, Phase III
Updated: 12/31/1969
New York State Psychiatric Institute
mi
from
New York, NY
Click here to add this to my saved trials
Oncology Clinical Trial
Study of the Safety, Pharmacokinetics and Efficacy of EDO-S101, in Patients With Advanced Solid Tumors
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Stanford University Medical Center
mi
from
Palo Alto, CA
Click here to add this to my saved trials
Osteoarthritis Clinical Trial
Antimicrobial Barrier Dressing Versus Closed-incision Negative Pressure Therapy in the Obese Primary Total Joint Arthroplasty
Status: Enrolling, Phase III
Updated: 12/31/1969
New York University School of Medicine
mi
from
New York, NY
Click here to add this to my saved trials
Oncology, Reproductive Clinical Trial
Adavosertib, External Beam Radiation Therapy, and Cisplatin in Treating Patients With Cervical, Vaginal, or Uterine Cancer
Status: Enrolling, Phase I
Updated: 12/31/1969
University of Colorado Hospital
mi
from
Aurora, CO
Click here to add this to my saved trials
Endocrinology, Ophthalmology Clinical Trial
PROMINENT-Eye Ancillary Study (Protocol AD)
Status: Enrolling, Phase III
Updated: 12/31/1969
Kellogg Eye Center at University of Michigan
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Endocrinology, Ophthalmology Clinical Trial
PROMINENT-Eye Ancillary Study (Protocol AD)
Status: Enrolling, Phase III
Updated: 12/31/1969
Ophthalmic Consultants of Boston
mi
from
Boston, MA
Click here to add this to my saved trials
Endocrinology, Ophthalmology Clinical Trial
PROMINENT-Eye Ancillary Study (Protocol AD)
Status: Enrolling, Phase III
Updated: 12/31/1969
Henry Ford Health System, Dept of Ophthalmology and Eye Care Services
mi
from
Detroit, MI
Click here to add this to my saved trials
Endocrinology, Ophthalmology Clinical Trial
PROMINENT-Eye Ancillary Study (Protocol AD)
Status: Enrolling, Phase III
Updated: 12/31/1969
Retina Vitreous Center
mi
from
Edmond, OK
Click here to add this to my saved trials
Endocrinology, Ophthalmology Clinical Trial
PROMINENT-Eye Ancillary Study (Protocol AD)
Status: Enrolling, Phase III
Updated: 12/31/1969
Retina and Vitreous Associates of Kentucky
mi
from
Lexington, KY
Click here to add this to my saved trials
Endocrinology, Ophthalmology Clinical Trial
PROMINENT-Eye Ancillary Study (Protocol AD)
Status: Enrolling, Phase III
Updated: 12/31/1969
Retina Macula Specialists of Miami
mi
from
Miami, FL
Click here to add this to my saved trials
Endocrinology, Ophthalmology Clinical Trial
PROMINENT-Eye Ancillary Study (Protocol AD)
Status: Enrolling, Phase III
Updated: 12/31/1969
John-Kenyon American Eye Institute
mi
from
New Albany, IN
Click here to add this to my saved trials
Endocrinology, Ophthalmology Clinical Trial
PROMINENT-Eye Ancillary Study (Protocol AD)
Status: Enrolling, Phase III
Updated: 12/31/1969
MaculaCare
mi
from
New York, NY
Click here to add this to my saved trials
Endocrinology, Ophthalmology Clinical Trial
PROMINENT-Eye Ancillary Study (Protocol AD)
Status: Enrolling, Phase III
Updated: 12/31/1969
Retina-Vitreous Surgeons of Central New York, PC
mi
from
Syracuse, NY
Click here to add this to my saved trials
Endocrinology, Ophthalmology Clinical Trial
PROMINENT-Eye Ancillary Study (Protocol AD)
Status: Enrolling, Phase III
Updated: 12/31/1969
Retinal Consultants of Southern California Medical Group, Inc.
mi
from
Westlake Village, CA
Click here to add this to my saved trials
Dermatitis, Atopic Clinical Trial
Safety, Pharmacokinetics and Efficacy of Dupilumab in Patients ≥6 Months to
Status: Enrolling, Phase II, III
Updated: 12/31/1969
Regeneron Study Site
mi
from
Minneapolis, MN
Click here to add this to my saved trials
HIV Clinical Trial
Adoptive Transfer of Haploidentical Natural Killer Cells and IL-2
Status: Enrolling, Phase II
Updated: 12/31/1969
University of Minnesota Medical Center
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Dermatology / Plastic Surgery Clinical Trial
Role of Neurogenic Inflammation and Topical 6% Gabapentin Therapy in Symptomatic Scarring Alopecia
Status: Enrolling, Phase
Updated: 12/31/1969
Univ of Minnesota
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Early Feasibility Study of the AccuCinch® Ventricular Repair System - The CorCinch-FMR Study
Status: Enrolling
Updated: 12/31/1969
Columbia University Medical Center
mi
from
New York, NY
Click here to add this to my saved trials
Neurology, Other Clinical Trial
Dietary Approaches to Treat Multiple Sclerosis-Related Fatigue Study
Status: Enrolling
Updated: 12/31/1969
University of Iowa Hospitals and Clinics
mi
from
Iowa City, IA
Click here to add this to my saved trials
Amyotrophic Lateral Sclerosis Clinical Trial
Delineating Swallowing Impairment and Decline in ALS
Status: Enrolling, Phase
Updated: 12/31/1969
University of South Florida
mi
from
Tampa, FL
Click here to add this to my saved trials
Oncology Clinical Trial
A Study to Evaluate the Safety, Tolerability, and Activity of TAK-931 in Participants With Metastatic Pancreatic Cancer, Metastatic Colorectal Cancer, and Other Advanced Solid Tumors
Status: Enrolling, Phase II
Updated: 12/31/1969
Allina Health, Virginia Piper Cancer Institute
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Post-Traumatic Headache Clinical Trial
A Study Comparing 1 Subcutaneous Dose Regimen of Fremanezumab Versus Placebo for the Prevention of PPTH
Status: Enrolling, Phase II
Updated: 12/31/1969
Teva Investigational Site 44
mi
from
Fairfield, CT
Click here to add this to my saved trials
Post-Traumatic Headache Clinical Trial
A Study Comparing 1 Subcutaneous Dose Regimen of Fremanezumab Versus Placebo for the Prevention of PPTH
Status: Enrolling, Phase II
Updated: 12/31/1969
Teva Investigational Site 10147
mi
from
Long Beach, CA
Click here to add this to my saved trials
Post-Traumatic Headache Clinical Trial
A Study Comparing 1 Subcutaneous Dose Regimen of Fremanezumab Versus Placebo for the Prevention of PPTH
Status: Enrolling, Phase II
Updated: 12/31/1969
Teva Investigational Site 10183
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Post-Traumatic Headache Clinical Trial
A Study Comparing 1 Subcutaneous Dose Regimen of Fremanezumab Versus Placebo for the Prevention of PPTH
Status: Enrolling, Phase II
Updated: 12/31/1969
Teva Investigational Site 69
mi
from
San Francisco, CA
Click here to add this to my saved trials
Post-Traumatic Headache Clinical Trial
A Study Comparing 1 Subcutaneous Dose Regimen of Fremanezumab Versus Placebo for the Prevention of PPTH
Status: Enrolling, Phase II
Updated: 12/31/1969
Teva Investigational Site
mi
from
Tampa, FL
Click here to add this to my saved trials
Oncology Clinical Trial
Ferumoxytol MRI in Assessing Response to Pembrolizumab in Patients With Brain Tumors From Melanoma and Glioblastoma
Status: Enrolling, Phase II
Updated: 12/20/2017
OHSU Knight Cancer Institute
mi
from
Portland, OR
Click here to add this to my saved trials
Degenerative Disc Disease Clinical Trial
Study to Evaluate the Safety and Preliminary Efficacy of IDCT, a Treatment for Symptomatic Lumbar Intervertebral Disc Degeneration
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Alabama Clinical Therapeutics, Llc
mi
from
Birmingham, AL
Click here to add this to my saved trials
Valve Heart Disease Clinical Trial
Post-surgical Aortic Hemodynamics After Aortic Valve Replacement
Status: Enrolling
Updated: 11/30/2017
Northwestern University
mi
from
Chicago, IL
Click here to add this to my saved trials
Pain, Postoperative Clinical Trial
Bupivacaine Liposomal Injection (Exparel) for Postsurgical Analgesia in Patients Undergoing Laparoscopic Gastric Bypass
Status: Enrolling, Phase IV
Updated: 11/17/2017
Cleveland Clinic
mi
from
Cleveland, OH
Click here to add this to my saved trials
Hematopoietic and Lymphoid Cell Neoplasm Clinical Trial
A Two Step Approach to Allogeneic Hematopoietic Stem Cell Transplantation for Patients With Hematologic Malignancies-Increasing GVT Effects Without Increasing Toxicity
Status: Enrolling, Phase II
Updated: 12/31/1969
Sidney Kimmel Cancer Center - Thomas Jefferson University
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Coronary Artery Lesions Clinical Trial
XIENCE 90: A Safety Evaluation of 3-month DAPT After XIENCE Implantation for HBR Patients.
Status: Enrolling
Updated: 12/31/1969
Mount Sinai Hospital
mi
from
New York, NY
Click here to add this to my saved trials
Coronary Artery Lesions Clinical Trial
XIENCE 90: A Safety Evaluation of 3-month DAPT After XIENCE Implantation for HBR Patients.
Status: Enrolling
Updated: 12/31/1969
North Georgia Heart Foundation
mi
from
Gainesville, GA
Click here to add this to my saved trials
Coronary Artery Lesions Clinical Trial
XIENCE 90: A Safety Evaluation of 3-month DAPT After XIENCE Implantation for HBR Patients.
Status: Enrolling
Updated: 12/31/1969
Memorial Hermann-Hermann Hospital
mi
from
Houston, TX
Click here to add this to my saved trials
Coronary Artery Lesions Clinical Trial
XIENCE 90: A Safety Evaluation of 3-month DAPT After XIENCE Implantation for HBR Patients.
Status: Enrolling
Updated: 12/31/1969
Franciscan Physician Network-Indiana Heart Physicians
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Coronary Artery Lesions Clinical Trial
XIENCE 90: A Safety Evaluation of 3-month DAPT After XIENCE Implantation for HBR Patients.
Status: Enrolling
Updated: 12/31/1969
McLaren Greater Lansing
mi
from
Lansing, MI
Click here to add this to my saved trials
Coronary Artery Lesions Clinical Trial
XIENCE 90: A Safety Evaluation of 3-month DAPT After XIENCE Implantation for HBR Patients.
Status: Enrolling
Updated: 12/31/1969
St. Vincents Medical Center
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Coronary Artery Lesions Clinical Trial
XIENCE 90: A Safety Evaluation of 3-month DAPT After XIENCE Implantation for HBR Patients.
Status: Enrolling
Updated: 12/31/1969
Integris Baptist Medical Center
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Coronary Artery Lesions Clinical Trial
XIENCE 90: A Safety Evaluation of 3-month DAPT After XIENCE Implantation for HBR Patients.
Status: Enrolling
Updated: 12/31/1969
Allegheny General Hospital
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Coronary Artery Lesions Clinical Trial
XIENCE 90: A Safety Evaluation of 3-month DAPT After XIENCE Implantation for HBR Patients.
Status: Enrolling
Updated: 12/31/1969
Washington University School of Medicine
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Coronary Artery Lesions Clinical Trial
XIENCE 90: A Safety Evaluation of 3-month DAPT After XIENCE Implantation for HBR Patients.
Status: Enrolling
Updated: 12/31/1969
St. Joseph's Hospital Health Center
mi
from
Syracuse, NY
Click here to add this to my saved trials
Coronary Artery Lesions Clinical Trial
XIENCE 90: A Safety Evaluation of 3-month DAPT After XIENCE Implantation for HBR Patients.
Status: Enrolling
Updated: 12/31/1969
Torrance Memorial Medical Center
mi
from
Torrance, CA
Click here to add this to my saved trials
Coronary Artery Lesions Clinical Trial
XIENCE 90: A Safety Evaluation of 3-month DAPT After XIENCE Implantation for HBR Patients.
Status: Enrolling
Updated: 12/31/1969
Munson Medical Center
mi
from
Traverse City, MI
Click here to add this to my saved trials
Advanced Head and Neck Squamous Cell Carcinoma Clinical Trial
A Study of CDX-3379 and Cetuximab and in Patients With Advanced Head and Neck Squamous Cell Carcinoma
Status: Enrolling, Phase II
Updated: 12/31/1969
Washington University School of Medicine
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Oncology Clinical Trial
PF-06804103 Dose Escalation in HER2 Positive Solid Tumors
Status: Enrolling, Phase I
Updated: 12/31/1969
Cedars-Sinai Medical Center/Samuel Oschin Comprehensive Cancer institute
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Oncology Clinical Trial
PF-06804103 Dose Escalation in HER2 Positive Solid Tumors
Status: Enrolling, Phase I
Updated: 12/31/1969
The University of Arizona Cancer Center - North Campus
mi
from
Tucson, AZ
Click here to add this to my saved trials
Neurology Clinical Trial
Study to Evaluate the Efficacy and Safety of Perampanel as Monotherapy or First Adjunctive Therapy in Subjects With Partial Onset Seizures With or Without Secondarily Generalized Seizures or With Primary Generalized Tonic-Clonic Seizures
Status: Enrolling, Phase IV
Updated: 12/31/1969
Johns Hopkins Medicine
mi
from
Baltimore, MD
Click here to add this to my saved trials
Neurology Clinical Trial
Study to Evaluate the Efficacy and Safety of Perampanel as Monotherapy or First Adjunctive Therapy in Subjects With Partial Onset Seizures With or Without Secondarily Generalized Seizures or With Primary Generalized Tonic-Clonic Seizures
Status: Enrolling, Phase IV
Updated: 12/31/1969
Rush University Medical Center
mi
from
Chicago, IL
Click here to add this to my saved trials
Neurology Clinical Trial
Study to Evaluate the Efficacy and Safety of Perampanel as Monotherapy or First Adjunctive Therapy in Subjects With Partial Onset Seizures With or Without Secondarily Generalized Seizures or With Primary Generalized Tonic-Clonic Seizures
Status: Enrolling, Phase IV
Updated: 12/31/1969
Michigan State University
mi
from
East Lansing, MI
Click here to add this to my saved trials
Neurology Clinical Trial
Study to Evaluate the Efficacy and Safety of Perampanel as Monotherapy or First Adjunctive Therapy in Subjects With Partial Onset Seizures With or Without Secondarily Generalized Seizures or With Primary Generalized Tonic-Clonic Seizures
Status: Enrolling, Phase IV
Updated: 12/31/1969
JFK Medical Center
mi
from
Edison, NJ
Click here to add this to my saved trials
Neurology Clinical Trial
Study to Evaluate the Efficacy and Safety of Perampanel as Monotherapy or First Adjunctive Therapy in Subjects With Partial Onset Seizures With or Without Secondarily Generalized Seizures or With Primary Generalized Tonic-Clonic Seizures
Status: Enrolling, Phase IV
Updated: 12/31/1969
Barrow Neurological Institute
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Irritable Bowel Syndrome Clinical Trial
Study to Explore the Therapeutic Effect of Eluxadoline in Treating Irritable Bowel Syndrome With Diarrhea in Children.
Status: Enrolling, Phase II
Updated: 12/31/1969
Envision Clinical Research, LLC
mi
from
Laredo, TX
Click here to add this to my saved trials
Irritable Bowel Syndrome Clinical Trial
Study to Explore the Therapeutic Effect of Eluxadoline in Treating Irritable Bowel Syndrome With Diarrhea in Children.
Status: Enrolling, Phase II
Updated: 12/31/1969
Michael W. Simon, MD, PSC
mi
from
Nicholasville, KY
Click here to add this to my saved trials
Irritable Bowel Syndrome Clinical Trial
Study to Explore the Therapeutic Effect of Eluxadoline in Treating Irritable Bowel Syndrome With Diarrhea in Children.
Status: Enrolling, Phase II
Updated: 12/31/1969
University of California at San Francisco
mi
from
San Francisco, CA
Click here to add this to my saved trials
Dengue Clinical Trial
Immunogenicity and Safety of Tetravalent Dengue Vaccine (TDV) Administered With a Yellow Fever Vaccine in Adults
Status: Enrolling, Phase III
Updated: 12/31/1969
Regional Clinical Research, Inc.
mi
from
Endwell, NY
Click here to add this to my saved trials
Dengue Clinical Trial
Immunogenicity and Safety of Tetravalent Dengue Vaccine (TDV) Administered With a Yellow Fever Vaccine in Adults
Status: Enrolling, Phase III
Updated: 12/31/1969
The Center for Pharmaceutical Research, P.C.
mi
from
Kansas City, MO
Click here to add this to my saved trials
Oncology, Reproductive Clinical Trial
Evaluation of Fluciclovine Uptake in Patients With Cervical, Ovarian Epithelial or Endometrial Cancers.
Status: Enrolling, Phase IV
Updated: 12/31/1969
Loyola University Medical Center
mi
from
Maywood, IL
Click here to add this to my saved trials
Severe Osteoarthritis of the Knee Clinical Trial
An Open Label Extension Study to Assess the Safety of Long-Term Treatment With Ampion for Severe OA of the Knee
Status: Enrolling, Phase III
Updated: 12/19/2017
Northwest Clinical Research Center
mi
from
Bellevue, WA
Click here to add this to my saved trials
Severe Osteoarthritis of the Knee Clinical Trial
An Open Label Extension Study to Assess the Safety of Long-Term Treatment With Ampion for Severe OA of the Knee
Status: Enrolling, Phase III
Updated: 12/19/2017
Core Orthopaedic Medical Center
mi
from
Encinitas, CA
Click here to add this to my saved trials
Immunology / Infectious Diseases Clinical Trial
Study to Evaluate BIIB059 in Cutaneous Lupus Erythematosus (CLE) With or Without Systemic Lupus Erythematosus (SLE)
Status: Enrolling, Phase II
Updated: 12/31/1969
Joint and Muscle Research Institute
mi
from
Charlotte, NC
Click here to add this to my saved trials
Immunology / Infectious Diseases Clinical Trial
Study to Evaluate BIIB059 in Cutaneous Lupus Erythematosus (CLE) With or Without Systemic Lupus Erythematosus (SLE)
Status: Enrolling, Phase II
Updated: 12/31/1969
Clinical Research of West Florida - Corporate
mi
from
Clearwater, FL
Click here to add this to my saved trials
Immunology / Infectious Diseases Clinical Trial
Study to Evaluate BIIB059 in Cutaneous Lupus Erythematosus (CLE) With or Without Systemic Lupus Erythematosus (SLE)
Status: Enrolling, Phase II
Updated: 12/31/1969
U.T. Southwestern Medical Center
mi
from
Dallas, TX
Click here to add this to my saved trials
Immunology / Infectious Diseases Clinical Trial
Study to Evaluate BIIB059 in Cutaneous Lupus Erythematosus (CLE) With or Without Systemic Lupus Erythematosus (SLE)
Status: Enrolling, Phase II
Updated: 12/31/1969
Denver Arthritis Clinic
mi
from
Denver, CO
Click here to add this to my saved trials
Immunology / Infectious Diseases Clinical Trial
Study to Evaluate BIIB059 in Cutaneous Lupus Erythematosus (CLE) With or Without Systemic Lupus Erythematosus (SLE)
Status: Enrolling, Phase II
Updated: 12/31/1969
TriWest Research Associates, LLC
mi
from
El Cajon, CA
Click here to add this to my saved trials
Immunology / Infectious Diseases Clinical Trial
Study to Evaluate BIIB059 in Cutaneous Lupus Erythematosus (CLE) With or Without Systemic Lupus Erythematosus (SLE)
Status: Enrolling, Phase II
Updated: 12/31/1969
University of Tennessee Health Sciences Center
mi
from
Memphis, TN
Click here to add this to my saved trials
Immunology / Infectious Diseases Clinical Trial
Study to Evaluate BIIB059 in Cutaneous Lupus Erythematosus (CLE) With or Without Systemic Lupus Erythematosus (SLE)
Status: Enrolling, Phase II
Updated: 12/31/1969
Low Country Rheumatology, PA
mi
from
North Charleston, SC
Click here to add this to my saved trials
Immunology / Infectious Diseases Clinical Trial
Study to Evaluate BIIB059 in Cutaneous Lupus Erythematosus (CLE) With or Without Systemic Lupus Erythematosus (SLE)
Status: Enrolling, Phase II
Updated: 12/31/1969
DMI Research, Inc
mi
from
Pinellas Park, FL
Click here to add this to my saved trials
Immunology / Infectious Diseases Clinical Trial
Study to Evaluate BIIB059 in Cutaneous Lupus Erythematosus (CLE) With or Without Systemic Lupus Erythematosus (SLE)
Status: Enrolling, Phase II
Updated: 12/31/1969
The Valley Hospital
mi
from
Ridgewood, NJ
Click here to add this to my saved trials
Immunology / Infectious Diseases Clinical Trial
Study to Evaluate BIIB059 in Cutaneous Lupus Erythematosus (CLE) With or Without Systemic Lupus Erythematosus (SLE)
Status: Enrolling, Phase II
Updated: 12/31/1969
Washington University School of Medicine
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Immunology / Infectious Diseases Clinical Trial
Study to Evaluate BIIB059 in Cutaneous Lupus Erythematosus (CLE) With or Without Systemic Lupus Erythematosus (SLE)
Status: Enrolling, Phase II
Updated: 12/31/1969
University Clinical Trials, Inc.
mi
from
San Diego, CA
Click here to add this to my saved trials
Immunology / Infectious Diseases Clinical Trial
Study to Evaluate BIIB059 in Cutaneous Lupus Erythematosus (CLE) With or Without Systemic Lupus Erythematosus (SLE)
Status: Enrolling, Phase II
Updated: 12/31/1969
Robin K. Dore M.D., Inc.
mi
from
Tustin, CA
Click here to add this to my saved trials
Melanoma Clinical Trial
Study of DS-8273a With Nivolumab in Unresectable Stage III or Stage IV Melanoma
Status: Enrolling, Phase I
Updated: 12/31/1969
Laura And Isaac Perlmutter Cancer Center
mi
from
New York, NY
Click here to add this to my saved trials
Acute Myeloid Leukemia Clinical Trial
A Trial of the FMS-like Tyrosine Kinase 3 (FLT3) Inhibitor Gilteritinib Administered as Maintenance Therapy Following Allogeneic Transplant for Patients With FLT3/Internal Tandem Duplication (ITD) Acute Myeloid Leukemia (AML)
Status: Enrolling, Phase III
Updated: 12/31/1969
Emory University
mi
from
Atlanta, GA
Click here to add this to my saved trials
Acute Myeloid Leukemia Clinical Trial
A Trial of the FMS-like Tyrosine Kinase 3 (FLT3) Inhibitor Gilteritinib Administered as Maintenance Therapy Following Allogeneic Transplant for Patients With FLT3/Internal Tandem Duplication (ITD) Acute Myeloid Leukemia (AML)
Status: Enrolling, Phase III
Updated: 12/31/1969
University of Alabama at Birmingham
mi
from
Birmingham, AL
Click here to add this to my saved trials
Acute Myeloid Leukemia Clinical Trial
A Trial of the FMS-like Tyrosine Kinase 3 (FLT3) Inhibitor Gilteritinib Administered as Maintenance Therapy Following Allogeneic Transplant for Patients With FLT3/Internal Tandem Duplication (ITD) Acute Myeloid Leukemia (AML)
Status: Enrolling, Phase III
Updated: 12/31/1969
Massachusetts General Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
Acute Myeloid Leukemia Clinical Trial
A Trial of the FMS-like Tyrosine Kinase 3 (FLT3) Inhibitor Gilteritinib Administered as Maintenance Therapy Following Allogeneic Transplant for Patients With FLT3/Internal Tandem Duplication (ITD) Acute Myeloid Leukemia (AML)
Status: Enrolling, Phase III
Updated: 12/31/1969
Vanderbilt University Medical Center
mi
from
Nashville, TN
Click here to add this to my saved trials
Acute Myeloid Leukemia Clinical Trial
A Trial of the FMS-like Tyrosine Kinase 3 (FLT3) Inhibitor Gilteritinib Administered as Maintenance Therapy Following Allogeneic Transplant for Patients With FLT3/Internal Tandem Duplication (ITD) Acute Myeloid Leukemia (AML)
Status: Enrolling, Phase III
Updated: 12/31/1969
Augusta University
mi
from
Augusta, GA
Click here to add this to my saved trials
Acute Myeloid Leukemia Clinical Trial
A Trial of the FMS-like Tyrosine Kinase 3 (FLT3) Inhibitor Gilteritinib Administered as Maintenance Therapy Following Allogeneic Transplant for Patients With FLT3/Internal Tandem Duplication (ITD) Acute Myeloid Leukemia (AML)
Status: Enrolling, Phase III
Updated: 12/31/1969
Dana-Farber Cancer Institute
mi
from
Boston, MA
Click here to add this to my saved trials
Acute Myeloid Leukemia Clinical Trial
A Trial of the FMS-like Tyrosine Kinase 3 (FLT3) Inhibitor Gilteritinib Administered as Maintenance Therapy Following Allogeneic Transplant for Patients With FLT3/Internal Tandem Duplication (ITD) Acute Myeloid Leukemia (AML)
Status: Enrolling, Phase III
Updated: 12/31/1969
University of Virginia
mi
from
Charlottesville, VA
Click here to add this to my saved trials
Acute Myeloid Leukemia Clinical Trial
A Trial of the FMS-like Tyrosine Kinase 3 (FLT3) Inhibitor Gilteritinib Administered as Maintenance Therapy Following Allogeneic Transplant for Patients With FLT3/Internal Tandem Duplication (ITD) Acute Myeloid Leukemia (AML)
Status: Enrolling, Phase III
Updated: 12/31/1969
West Virginia University Hospital
mi
from
Morgantown, WV
Click here to add this to my saved trials
Acute Myeloid Leukemia Clinical Trial
A Trial of the FMS-like Tyrosine Kinase 3 (FLT3) Inhibitor Gilteritinib Administered as Maintenance Therapy Following Allogeneic Transplant for Patients With FLT3/Internal Tandem Duplication (ITD) Acute Myeloid Leukemia (AML)
Status: Enrolling, Phase III
Updated: 12/31/1969
Virginia Commonwealth University
mi
from
Richmond, VA
Click here to add this to my saved trials
Acute Myeloid Leukemia Clinical Trial
A Trial of the FMS-like Tyrosine Kinase 3 (FLT3) Inhibitor Gilteritinib Administered as Maintenance Therapy Following Allogeneic Transplant for Patients With FLT3/Internal Tandem Duplication (ITD) Acute Myeloid Leukemia (AML)
Status: Enrolling, Phase III
Updated: 12/31/1969
Washington University in St. Louis
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Acute Myeloid Leukemia Clinical Trial
A Trial of the FMS-like Tyrosine Kinase 3 (FLT3) Inhibitor Gilteritinib Administered as Maintenance Therapy Following Allogeneic Transplant for Patients With FLT3/Internal Tandem Duplication (ITD) Acute Myeloid Leukemia (AML)
Status: Enrolling, Phase III
Updated: 12/31/1969
University of California at San Francisco
mi
from
San Francisco, CA
Click here to add this to my saved trials
Acute Myeloid Leukemia Clinical Trial
A Trial of the FMS-like Tyrosine Kinase 3 (FLT3) Inhibitor Gilteritinib Administered as Maintenance Therapy Following Allogeneic Transplant for Patients With FLT3/Internal Tandem Duplication (ITD) Acute Myeloid Leukemia (AML)
Status: Enrolling, Phase III
Updated: 12/31/1969
Stanford University
mi
from
Stanford, CA
Click here to add this to my saved trials
Oncology Clinical Trial
Nivolumab and Brentuximab Vedotin After Stem Cell Transplant in Treating Patients With Relapsed or Refractory High-Risk Classical Hodgkin Lymphoma
Status: Enrolling, Phase II
Updated: 12/31/1969
City of Hope Medical Center
mi
from
Duarte, CA
Click here to add this to my saved trials
Oncology Clinical Trial
Nivolumab and Brentuximab Vedotin After Stem Cell Transplant in Treating Patients With Relapsed or Refractory High-Risk Classical Hodgkin Lymphoma
Status: Enrolling, Phase II
Updated: 12/31/1969
M D Anderson Cancer Center
mi
from
Houston, TX
Click here to add this to my saved trials
Oncology Clinical Trial
Nivolumab and Brentuximab Vedotin After Stem Cell Transplant in Treating Patients With Relapsed or Refractory High-Risk Classical Hodgkin Lymphoma
Status: Enrolling, Phase II
Updated: 12/31/1969
Memorial Sloan Kettering Cancer Center
mi
from
New York, NY
Click here to add this to my saved trials
Oncology Clinical Trial
Pembrolizumab and Vorinostat in Treating Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma, Follicular Lymphoma, or Hodgkin Lymphoma
Status: Enrolling, Phase I
Updated: 12/31/1969
Hackensack University Medical Center
mi
from
Hackensack, NJ
Click here to add this to my saved trials
Gastroenterology, Nephrology / Urology, Other Clinical Trial
Remote Ischemic Conditioning in Abdominal Surgery
Status: Enrolling
Updated: 12/31/1969
University Hospital
mi
from
Newark, NJ
Click here to add this to my saved trials
Oncology, Other Clinical Trial
CD19/CD22 Chimeric Antigen Receptor T Cells and Chemotherapy in Treating Children or Young Adults With Recurrent or Refractory CD19 Positive B Acute Lymphoblastic Leukemia
Status: Enrolling, Phase I
Updated: 12/31/1969
Lucile Packard Children's Hospital Stanford University
mi
from
Palo Alto, CA
Click here to add this to my saved trials
Parkinson Disease Clinical Trial
Motivational Interviewing and Physical Activity Change in Parkinson's Disease
Status: Enrolling
Updated: 12/31/1969
Northwestern Medicine
mi
from
Chicago, IL
Click here to add this to my saved trials
Gastroenterology, Immunology / Infectious Diseases Clinical Trial
Rollover Study of Cenicriviroc for the Treatment of Liver Fibrosis in Participants With Nonalcoholic Steatohepatitis
Status: Enrolling, Phase II
Updated: 5/1/2018
Tulane University Medical Center
mi
from
New Orleans, LA
Click here to add this to my saved trials
Dementia Clinical Trial
Escitalopram for Agitation in Alzheimer's Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
Columbia University
mi
from
New York, NY
Click here to add this to my saved trials
Dementia Clinical Trial
Escitalopram for Agitation in Alzheimer's Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
Ohio State University
mi
from
Columbus, OH
Click here to add this to my saved trials
Dementia Clinical Trial
Escitalopram for Agitation in Alzheimer's Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
Cleveland Clinic Lou Ruvo Center for Brain Health
mi
from
Las Vegas, NV
Click here to add this to my saved trials
Dementia Clinical Trial
Escitalopram for Agitation in Alzheimer's Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
University of Southern California Keck School of Medicine Memory and Aging Center
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Alzheimer Disease Clinical Trial
A Study of LY3002813 in Participants With Early Symptomatic Alzheimer's Disease (TRAILBLAZER-ALZ)
Status: Enrolling, Phase II
Updated: 12/31/1969
Josephson Wallack Munshower Neurology P.C
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Alzheimer Disease Clinical Trial
A Study of LY3002813 in Participants With Early Symptomatic Alzheimer's Disease (TRAILBLAZER-ALZ)
Status: Enrolling, Phase II
Updated: 12/31/1969
Hoag Memorial Hospital
mi
from
Newport Beach, CA
Click here to add this to my saved trials